J. Goldman & Co Lp Activity Analysis: Q2 2026 Portfolio Shifts Revealed
Insights into holdings changes by J. Goldman & Co Lp during the second quarter of 2026, highlighting key purchases and sales.
Q2 2026 Activity Overview
Last quarter, J. Goldman & Co Lp demonstrated active portfolio management with notable changes across various sectors.
Prominent Purchases in Q2 2026
J. Goldman & Co Lp significantly increased its holdings during the second quarter of 2026, focusing on several key areas:
- Warby Parker Inc (WRBY): The healthcare-focused company saw a substantial increase in shares held by J. Goldman & Co Lp.
- Grocery Outlet Holding Corp (GO): This consumer defensive stock experienced a massive jump in share count, indicating strong confidence from the investor.
- SentinelOne Inc (S): Technology sector focus continued with J. Goldman & Co Lp acquiring a significant number of shares in this healthcare technology company.
- SPDR Select Sector SOE ETF (XLP): This exchange-traded fund, categorized under consumer staples, was added to the portfolio or significantly increased by J. Goldman & Co Lp.
Detailed Breakdown of Increases
The investor's buying activity included:
- Warby Parker Inc (WRBY): Shares increased by 59.51%, suggesting either a new position or substantial accumulation.
- Grocery Outlet Holding Corp (GO): A staggering increase of 193.78% in shares, pointing to aggressive buying.
- SPDR Select Sector SOE ETF (XLP): J. Goldman & Co Lp added a substantial position during this period.
Sales and Reductions Observed
In contrast, the investor also divested from certain holdings or reduced positions significantly:
- ProTara Therapeutics Inc (TARA): J. Goldman & Co Lp sold a considerable portion of its stake in this healthcare company.
- MannKind Corp (MNKD): The investor exited their position entirely, as the share count decreased by 100%.
Conclusion on Portfolio Strategy
J. Goldman & Co Lp's Q2 2026 activity reflects a dynamic investment approach focused on growth sectors and selective divestment. The significant increases in consumer defensive, healthcare technology, and exchange-traded fund positions suggest an investor leaning towards stability alongside high-growth opportunities.